SILVERARC CAPITAL MANAGEMENT, LLC

Position in KOD — Kodiak Sciences Inc.

CIK 1816307 BOSTON, MA

Position in KOD

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$37,812,371

+$9,205,880 QoQ

Shares Held

991,930

-3.0% QoQ

Ownership

1.59%

of shares outstanding

% of Portfolio

4.46%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SILVERARC CAPITAL MANAGEMENT, LLC holds $784,099,188 across 56 Biotechnology names. KOD ranks #6 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KALV	KalVista Pharmaceuticals, Inc.	2,876,407	$57,902,072
2	DNTH	Dianthus Therapeutics, Inc. /DE/	654,746	$54,946,284
3	COGT	Cogent Biosciences, Inc.	1,314,189	$50,583,134
4	CELC	Celcuity Inc.	357,903	$40,851,048
5	IMNM	Immunome Inc.	1,850,278	$40,465,579
6	KOD	Kodiak Sciences Inc. This page	991,930	$37,812,371
7	NUVL	Nuvalent, Inc.	354,914	$36,360,939
8	ABVX	Abivax S.A.	302,530	$33,686,715

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,812,371	991,930	-3.0%	Shares	Sole	2026-05-14
2025-12-31	$28,606,491	1,023,122	+2.3%	Shares	Sole	2026-02-12
2025-09-30	$16,370,000	1,000,000	+149.0%	Shares	Sole	2025-11-12
2025-06-30	$1,497,744	401,540	-9.1%	Shares	Sole	2025-08-14
2025-03-31	$1,241,477	441,807	-55.8%	Shares	Sole	2025-05-14
2024-12-31	$9,950,000	1,000,000	+100.0%	Shares	Sole	2025-02-14
2024-09-30	$1,305,000	500,000	-52.9%	Shares	Sole	2024-11-14
2024-06-30	$2,495,845	1,062,062	-14.3%	Shares	Sole	2024-08-14
2024-03-31	$6,516,203	1,238,822	+23.9%	Shares	Sole	2024-05-15
2023-12-31	$3,040,000	1,000,000	-10.3%	Shares	Sole	2024-02-14
2023-09-30	$2,006,029	1,114,461	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.